• Policy
• MFDS approves emergency use of Pfizer’s oral COVID-19 drug
• by Lee, Tak-Sun Dec 28, 2021 05:50am

• Company
• ST Pharm has applied for phase 1 of the COVID-19 vaccine
• by Kim, Jin-Gu Dec 28, 2021 05:50am

• Company
• Ildong's new DM GLP-1 analog has acquired a new patent
• by Dec 28, 2021 05:49am

• Policy
• AstraZeneca Xigduo’s latecomers consecutively approved
• by Lee, Tak-Sun Dec 27, 2021 05:57am

• Company
• The development of Kcav's Mucovac is in full swing
• by Dec 27, 2021 05:57am

• Policy
• Roche applies for approval of its new drug faricimab
• by Lee, Tak-Sun Dec 27, 2021 05:56am

• Policy
• The suspension of execution for Legalon has been extended
• by Kim, Jung-Ju Dec 27, 2021 05:56am

• Company
• To introduce a phase 3 clinical drug preferential policy
• by Nho, Byung Chul Dec 27, 2021 05:56am

• Policy
• What are the variables for the release of Forxiga+ Januvia?
• by Lee, Tak-Sun Dec 24, 2021 05:49am

• Company
• Reimb of SGLT-2i combos unclear... nears PMS expiry
• by Eo, Yun-Ho Dec 24, 2021 05:49am